 Genevieve Sparagna
Concepts (346)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiolipins | 36 | 2025 | 81 | 4.290 |
Why?
| | Myocardium | 21 | 2021 | 982 | 1.930 |
Why?
| | Mitochondria, Heart | 18 | 2022 | 93 | 1.720 |
Why?
| | Mitochondria | 19 | 2025 | 838 | 1.120 |
Why?
| | Phospholipids | 11 | 2024 | 209 | 0.970 |
Why?
| | Acyltransferases | 11 | 2022 | 50 | 0.860 |
Why?
| | Heart Failure | 12 | 2016 | 2145 | 0.810 |
Why?
| | Barth Syndrome | 4 | 2022 | 8 | 0.780 |
Why?
| | Linoleic Acid | 6 | 2023 | 41 | 0.760 |
Why?
| | Fatty Acids | 10 | 2024 | 416 | 0.590 |
Why?
| | Myocytes, Cardiac | 7 | 2022 | 484 | 0.570 |
Why?
| | Rats | 26 | 2022 | 5244 | 0.520 |
Why?
| | Palmitic Acid | 4 | 2004 | 40 | 0.510 |
Why?
| | Electron Transport Complex III | 7 | 2017 | 14 | 0.500 |
Why?
| | Mitochondria, Liver | 6 | 2017 | 73 | 0.500 |
Why?
| | Diet, High-Fat | 4 | 2021 | 241 | 0.480 |
Why?
| | Animal Feed | 2 | 2013 | 52 | 0.430 |
Why?
| | Apoptosis | 8 | 2009 | 2485 | 0.420 |
Why?
| | Rats, Inbred SHR | 9 | 2013 | 43 | 0.420 |
Why?
| | Animals | 49 | 2025 | 34733 | 0.410 |
Why?
| | Berberine | 2 | 2021 | 6 | 0.380 |
Why?
| | Hypertrophy, Left Ventricular | 3 | 2009 | 127 | 0.370 |
Why?
| | Liver | 5 | 2024 | 1848 | 0.360 |
Why?
| | Electron Transport Complex IV | 4 | 2012 | 57 | 0.350 |
Why?
| | Calcium | 9 | 2010 | 1182 | 0.340 |
Why?
| | Phospholipases A2, Calcium-Independent | 1 | 2009 | 5 | 0.330 |
Why?
| | Cardiomyopathy, Hypertrophic | 2 | 2021 | 129 | 0.320 |
Why?
| | Saccharomyces cerevisiae | 3 | 2023 | 517 | 0.310 |
Why?
| | Fundulidae | 2 | 2018 | 2 | 0.310 |
Why?
| | Myocardial Reperfusion Injury | 3 | 2013 | 126 | 0.300 |
Why?
| | Diet | 3 | 2023 | 1214 | 0.280 |
Why?
| | Oxidation-Reduction | 11 | 2021 | 1013 | 0.280 |
Why?
| | Mitochondrial Membranes | 3 | 2025 | 39 | 0.280 |
Why?
| | Ischemia | 4 | 2024 | 396 | 0.280 |
Why?
| | Energy Metabolism | 3 | 2025 | 837 | 0.280 |
Why?
| | Dietary Fats | 5 | 2023 | 303 | 0.280 |
Why?
| | Diabetes, Gestational | 2 | 2021 | 306 | 0.270 |
Why?
| | Enzyme Inhibitors | 5 | 2013 | 828 | 0.270 |
Why?
| | Acclimatization | 2 | 2018 | 161 | 0.270 |
Why?
| | Electron Transport Complex I | 3 | 2021 | 38 | 0.260 |
Why?
| | Rats, Sprague-Dawley | 10 | 2009 | 2314 | 0.260 |
Why?
| | Mitochondrial Membrane Transport Proteins | 4 | 2010 | 33 | 0.260 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2012 | 165 | 0.250 |
Why?
| | Disease | 1 | 2006 | 95 | 0.250 |
Why?
| | Heart | 4 | 2017 | 650 | 0.240 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2023 | 367 | 0.240 |
Why?
| | Docosahexaenoic Acids | 3 | 2017 | 81 | 0.240 |
Why?
| | Transcription Factors | 6 | 2022 | 1636 | 0.240 |
Why?
| | Oligopeptides | 1 | 2025 | 256 | 0.210 |
Why?
| | Mice, Inbred C57BL | 6 | 2024 | 5279 | 0.210 |
Why?
| | Body Weight | 6 | 2021 | 935 | 0.210 |
Why?
| | Cardiomyopathy, Dilated | 3 | 2014 | 373 | 0.200 |
Why?
| | Escherichia coli Proteins | 1 | 2024 | 180 | 0.200 |
Why?
| | Glutathione | 1 | 2024 | 333 | 0.200 |
Why?
| | Reactive Oxygen Species | 3 | 2020 | 579 | 0.190 |
Why?
| | Fatty Acids, Unsaturated | 3 | 2021 | 93 | 0.190 |
Why?
| | Mitochondrial Diseases | 1 | 2022 | 89 | 0.180 |
Why?
| | Lipid Metabolism | 3 | 2020 | 491 | 0.180 |
Why?
| | Palmitates | 1 | 2000 | 18 | 0.180 |
Why?
| | Heart Diseases | 2 | 2021 | 356 | 0.180 |
Why?
| | Cytochrome c Group | 4 | 2001 | 41 | 0.180 |
Why?
| | Coenzyme A | 1 | 2020 | 7 | 0.180 |
Why?
| | Maternal-Fetal Exchange | 1 | 2021 | 159 | 0.170 |
Why?
| | B-Lymphocytes | 2 | 2022 | 816 | 0.170 |
Why?
| | Vascular Remodeling | 1 | 2022 | 186 | 0.170 |
Why?
| | Mice | 12 | 2024 | 16585 | 0.170 |
Why?
| | Ethanol | 1 | 2004 | 578 | 0.170 |
Why?
| | Male | 25 | 2024 | 63544 | 0.160 |
Why?
| | Heart Ventricles | 3 | 2020 | 779 | 0.160 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 271 | 0.160 |
Why?
| | Animals, Newborn | 6 | 2022 | 819 | 0.160 |
Why?
| | Physical Conditioning, Animal | 3 | 2008 | 226 | 0.160 |
Why?
| | Multienzyme Complexes | 2 | 2012 | 69 | 0.160 |
Why?
| | Disease Models, Animal | 8 | 2024 | 4016 | 0.150 |
Why?
| | Cell Culture Techniques | 1 | 2021 | 355 | 0.150 |
Why?
| | Dietary Supplements | 2 | 2021 | 534 | 0.150 |
Why?
| | Thermotolerance | 1 | 2018 | 8 | 0.150 |
Why?
| | Cells, Cultured | 8 | 2021 | 4058 | 0.150 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 222 | 0.150 |
Why?
| | Disease Susceptibility | 1 | 2020 | 339 | 0.150 |
Why?
| | Islets of Langerhans | 2 | 2021 | 792 | 0.150 |
Why?
| | Optic Atrophy, Autosomal Dominant | 1 | 2017 | 1 | 0.150 |
Why?
| | Cardiomyopathies | 1 | 2021 | 334 | 0.150 |
Why?
| | Dynamins | 1 | 2017 | 33 | 0.140 |
Why?
| | Intermittent Claudication | 1 | 2018 | 118 | 0.140 |
Why?
| | Eicosapentaenoic Acid | 3 | 2017 | 35 | 0.140 |
Why?
| | Mitochondrial Dynamics | 1 | 2017 | 30 | 0.140 |
Why?
| | Mitochondria, Muscle | 1 | 2018 | 109 | 0.140 |
Why?
| | Phosphatidylglycerols | 2 | 2023 | 24 | 0.140 |
Why?
| | Biological Transport | 6 | 2024 | 394 | 0.140 |
Why?
| | A Kinase Anchor Proteins | 1 | 2017 | 69 | 0.140 |
Why?
| | Kidney | 1 | 2024 | 1330 | 0.130 |
Why?
| | Mitochondrial Proteins | 2 | 2016 | 234 | 0.130 |
Why?
| | Phenotype | 3 | 2022 | 3063 | 0.130 |
Why?
| | Acute Kidney Injury | 1 | 2024 | 787 | 0.130 |
Why?
| | Hypertension | 4 | 2008 | 1240 | 0.130 |
Why?
| | Blood Pressure | 7 | 2013 | 1747 | 0.130 |
Why?
| | Sirtuins | 1 | 2016 | 35 | 0.130 |
Why?
| | Mitochondrial Trifunctional Protein, alpha Subunit | 1 | 2015 | 1 | 0.130 |
Why?
| | Signal Transduction | 5 | 2021 | 4863 | 0.120 |
Why?
| | Huntington Disease | 1 | 2016 | 48 | 0.120 |
Why?
| | Gene Expression | 4 | 2021 | 1477 | 0.120 |
Why?
| | Temperature | 1 | 2018 | 634 | 0.120 |
Why?
| | Female | 17 | 2022 | 68561 | 0.120 |
Why?
| | Electron Transport | 4 | 2021 | 111 | 0.120 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 448 | 0.120 |
Why?
| | Caspases | 4 | 2013 | 249 | 0.110 |
Why?
| | Linoleoyl-CoA Desaturase | 1 | 2013 | 3 | 0.110 |
Why?
| | Fatty Liver | 1 | 2016 | 230 | 0.110 |
Why?
| | Lymphocytes | 1 | 2016 | 369 | 0.110 |
Why?
| | Mice, Transgenic | 4 | 2021 | 2075 | 0.110 |
Why?
| | Spectrometry, Fluorescence | 1 | 1994 | 168 | 0.110 |
Why?
| | Cell Differentiation | 1 | 2021 | 1858 | 0.110 |
Why?
| | Oleic Acid | 3 | 2022 | 39 | 0.110 |
Why?
| | Aging | 3 | 2008 | 1769 | 0.100 |
Why?
| | Safflower Oil | 1 | 2012 | 5 | 0.100 |
Why?
| | Lysophospholipids | 2 | 2012 | 71 | 0.100 |
Why?
| | Citrate (si)-Synthase | 3 | 2007 | 58 | 0.100 |
Why?
| | Echocardiography | 5 | 2020 | 635 | 0.100 |
Why?
| | Peripheral Arterial Disease | 1 | 2018 | 458 | 0.100 |
Why?
| | Electron Transport Complex II | 1 | 2011 | 24 | 0.090 |
Why?
| | Time Factors | 4 | 2009 | 6593 | 0.090 |
Why?
| | Myocardial Contraction | 1 | 2013 | 336 | 0.090 |
Why?
| | Cryoelectron Microscopy | 1 | 2012 | 173 | 0.090 |
Why?
| | Humans | 19 | 2025 | 129705 | 0.090 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2011 | 145 | 0.090 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2001 | 45 | 0.090 |
Why?
| | Nutritional Status | 1 | 2013 | 327 | 0.090 |
Why?
| | Mass Spectrometry | 3 | 2017 | 659 | 0.090 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 2011 | 138 | 0.080 |
Why?
| | Ceramides | 2 | 2001 | 112 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 2022 | 0.080 |
Why?
| | Tissue Survival | 1 | 2009 | 17 | 0.080 |
Why?
| | Fish Oils | 1 | 2009 | 26 | 0.080 |
Why?
| | Metabolic Syndrome | 1 | 2013 | 339 | 0.080 |
Why?
| | Diacylglycerol Cholinephosphotransferase | 1 | 2008 | 1 | 0.080 |
Why?
| | Cytidine Diphosphate Diglycerides | 1 | 2008 | 3 | 0.080 |
Why?
| | Transferases (Other Substituted Phosphate Groups) | 1 | 2008 | 3 | 0.080 |
Why?
| | Phosphatidic Acids | 1 | 2008 | 9 | 0.080 |
Why?
| | Glycochenodeoxycholic Acid | 1 | 2008 | 14 | 0.080 |
Why?
| | Glycolysis | 2 | 2024 | 296 | 0.080 |
Why?
| | alpha-Tocopherol | 1 | 2008 | 32 | 0.080 |
Why?
| | Cardiotonic Agents | 1 | 2009 | 128 | 0.080 |
Why?
| | Rats, Inbred Strains | 1 | 2008 | 365 | 0.080 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2009 | 138 | 0.070 |
Why?
| | Superoxides | 2 | 2009 | 200 | 0.070 |
Why?
| | Adenosine Triphosphate | 3 | 2016 | 474 | 0.070 |
Why?
| | Cytosol | 2 | 2000 | 212 | 0.070 |
Why?
| | Molecular Structure | 1 | 2009 | 469 | 0.070 |
Why?
| | Calcium-Binding Proteins | 4 | 2008 | 213 | 0.070 |
Why?
| | Rats, Wistar | 3 | 2017 | 396 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2013 | 418 | 0.070 |
Why?
| | Obesity | 2 | 2021 | 2851 | 0.070 |
Why?
| | Blotting, Western | 4 | 2016 | 1189 | 0.070 |
Why?
| | Rats, Inbred BN | 1 | 2007 | 52 | 0.070 |
Why?
| | Phosphatidylethanolamines | 2 | 2017 | 74 | 0.070 |
Why?
| | Membrane Potentials | 2 | 2000 | 260 | 0.070 |
Why?
| | Heart Function Tests | 2 | 2020 | 61 | 0.070 |
Why?
| | Phosphatidylcholines | 2 | 2017 | 146 | 0.070 |
Why?
| | Genetic Diseases, X-Linked | 1 | 2006 | 25 | 0.070 |
Why?
| | Stress, Physiological | 1 | 2009 | 413 | 0.070 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 138 | 0.060 |
Why?
| | Cardiac Output, Low | 1 | 2006 | 66 | 0.060 |
Why?
| | Disease Progression | 1 | 2013 | 2612 | 0.060 |
Why?
| | Hypothyroidism | 1 | 2006 | 71 | 0.060 |
Why?
| | Oxidative Stress | 2 | 2024 | 1222 | 0.060 |
Why?
| | Syndrome | 1 | 2006 | 343 | 0.060 |
Why?
| | Cyclosporine | 2 | 2009 | 172 | 0.060 |
Why?
| | RNA, Messenger | 3 | 2020 | 2705 | 0.060 |
Why?
| | Chromatography, Gas | 1 | 2005 | 32 | 0.060 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2005 | 128 | 0.060 |
Why?
| | Pregnancy | 3 | 2022 | 6273 | 0.060 |
Why?
| | Reference Standards | 1 | 2005 | 168 | 0.060 |
Why?
| | Phospholipid Transfer Proteins | 1 | 2024 | 10 | 0.060 |
Why?
| | Escherichia coli K12 | 1 | 2024 | 8 | 0.060 |
Why?
| | Enzyme Activation | 2 | 2012 | 812 | 0.060 |
Why?
| | Protein Kinase C-epsilon | 1 | 2004 | 26 | 0.060 |
Why?
| | Membrane Proteins | 2 | 2008 | 1108 | 0.060 |
Why?
| | Linoleic Acids | 1 | 2023 | 4 | 0.060 |
Why?
| | Cell Respiration | 2 | 2017 | 92 | 0.050 |
Why?
| | Oxygen Consumption | 2 | 2021 | 680 | 0.050 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2007 | 387 | 0.050 |
Why?
| | Kinetics | 3 | 1998 | 1620 | 0.050 |
Why?
| | Cold Temperature | 1 | 2024 | 151 | 0.050 |
Why?
| | Caspase 3 | 2 | 2002 | 242 | 0.050 |
Why?
| | Membrane Transport Proteins | 1 | 2024 | 148 | 0.050 |
Why?
| | Models, Cardiovascular | 1 | 2004 | 193 | 0.050 |
Why?
| | Respiration | 1 | 2023 | 191 | 0.050 |
Why?
| | Acyl Coenzyme A | 2 | 2013 | 30 | 0.050 |
Why?
| | Coronary Circulation | 1 | 2003 | 138 | 0.050 |
Why?
| | Protein Kinase C | 1 | 2004 | 259 | 0.050 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2004 | 187 | 0.050 |
Why?
| | Hydrogen Peroxide | 2 | 2020 | 310 | 0.050 |
Why?
| | Glucose | 2 | 2021 | 977 | 0.050 |
Why?
| | Indomethacin | 1 | 2022 | 78 | 0.050 |
Why?
| | CD40 Antigens | 1 | 2022 | 87 | 0.050 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2024 | 322 | 0.050 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2022 | 145 | 0.050 |
Why?
| | Interleukin-4 | 1 | 2022 | 214 | 0.050 |
Why?
| | Cell Line | 2 | 2021 | 2768 | 0.050 |
Why?
| | Mice, Knockout | 2 | 2020 | 2778 | 0.050 |
Why?
| | Doxycycline | 1 | 2021 | 60 | 0.050 |
Why?
| | Metabolome | 1 | 2024 | 316 | 0.050 |
Why?
| | Phenylephrine | 1 | 2021 | 75 | 0.050 |
Why?
| | Mitochondrial Swelling | 1 | 2000 | 1 | 0.050 |
Why?
| | Myofibrils | 1 | 2021 | 50 | 0.040 |
Why?
| | Sarcomeres | 1 | 2021 | 92 | 0.040 |
Why?
| | Proto-Oncogene Proteins | 1 | 2004 | 636 | 0.040 |
Why?
| | Culture Media | 1 | 2021 | 169 | 0.040 |
Why?
| | Ruthenium Red | 2 | 2001 | 8 | 0.040 |
Why?
| | Caspase Inhibitors | 1 | 2000 | 83 | 0.040 |
Why?
| | Phosphatidylserines | 1 | 2000 | 89 | 0.040 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2002 | 187 | 0.040 |
Why?
| | Interleukin-10 | 1 | 2022 | 299 | 0.040 |
Why?
| | Spermine | 2 | 2001 | 28 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2021 | 315 | 0.040 |
Why?
| | Ion Channels | 1 | 2000 | 128 | 0.040 |
Why?
| | Escherichia coli | 1 | 2024 | 790 | 0.040 |
Why?
| | Child, Preschool | 3 | 2021 | 10565 | 0.040 |
Why?
| | Oxidative Phosphorylation | 2 | 2017 | 184 | 0.040 |
Why?
| | Respiratory Function Tests | 1 | 2022 | 594 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2004 | 1969 | 0.040 |
Why?
| | Swine | 2 | 2013 | 744 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 543 | 0.040 |
Why?
| | Metabolomics | 1 | 2024 | 592 | 0.040 |
Why?
| | Pancreas | 1 | 2021 | 307 | 0.040 |
Why?
| | Fluorescent Dyes | 1 | 2000 | 319 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2022 | 880 | 0.040 |
Why?
| | Ankle Brachial Index | 1 | 2018 | 37 | 0.040 |
Why?
| | Lipids | 2 | 2012 | 614 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 423 | 0.040 |
Why?
| | Fibrosis | 1 | 2021 | 521 | 0.040 |
Why?
| | DNA, Mitochondrial | 1 | 2020 | 194 | 0.040 |
Why?
| | Organ Size | 2 | 2009 | 448 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 1999 | 229 | 0.040 |
Why?
| | Cellular Microenvironment | 1 | 2018 | 79 | 0.040 |
Why?
| | Isolated Heart Preparation | 1 | 2017 | 6 | 0.040 |
Why?
| | Atrial Natriuretic Factor | 2 | 2009 | 56 | 0.040 |
Why?
| | Ventricular Remodeling | 1 | 2020 | 255 | 0.040 |
Why?
| | Aged | 3 | 2018 | 22113 | 0.040 |
Why?
| | Insulin | 2 | 2021 | 2313 | 0.030 |
Why?
| | Enzymes | 1 | 2017 | 65 | 0.030 |
Why?
| | Protein Binding | 2 | 2012 | 2088 | 0.030 |
Why?
| | Myosin Heavy Chains | 2 | 2009 | 173 | 0.030 |
Why?
| | Lipogenesis | 1 | 2016 | 56 | 0.030 |
Why?
| | Adiposity | 1 | 2021 | 507 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2021 | 819 | 0.030 |
Why?
| | Myocardial Infarction | 1 | 2003 | 1032 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2020 | 1700 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 2 | 2008 | 863 | 0.030 |
Why?
| | Middle Aged | 3 | 2018 | 31103 | 0.030 |
Why?
| | Adult | 3 | 2022 | 35595 | 0.030 |
Why?
| | Hepatocytes | 1 | 2016 | 217 | 0.030 |
Why?
| | Calcium Channels | 3 | 2001 | 149 | 0.030 |
Why?
| | Herpesvirus 4, Human | 1 | 2016 | 153 | 0.030 |
Why?
| | Child | 3 | 2021 | 20963 | 0.030 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2021 | 544 | 0.030 |
Why?
| | Hypoxia | 1 | 2022 | 1073 | 0.030 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2016 | 93 | 0.030 |
Why?
| | Infant | 2 | 2021 | 9097 | 0.030 |
Why?
| | Atherosclerosis | 1 | 2018 | 392 | 0.030 |
Why?
| | Egtazic Acid | 1 | 1994 | 42 | 0.030 |
Why?
| | Age Factors | 2 | 2014 | 3145 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3363 | 0.030 |
Why?
| | Automation | 1 | 1994 | 82 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1696 | 0.030 |
Why?
| | DNA | 1 | 2001 | 1406 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1707 | 0.030 |
Why?
| | Ventricular Function, Left | 2 | 2009 | 527 | 0.030 |
Why?
| | Cytochrome Reductases | 1 | 2012 | 3 | 0.030 |
Why?
| | Mitochondrial Trifunctional Protein | 1 | 2012 | 1 | 0.030 |
Why?
| | Palmitoyl Coenzyme A | 1 | 2012 | 2 | 0.030 |
Why?
| | Phospholipases | 1 | 2012 | 12 | 0.030 |
Why?
| | Proteolipids | 1 | 2012 | 30 | 0.030 |
Why?
| | Ubiquinone | 1 | 2012 | 24 | 0.030 |
Why?
| | Swine, Miniature | 1 | 2013 | 76 | 0.030 |
Why?
| | Weight Gain | 1 | 2016 | 505 | 0.030 |
Why?
| | Thyroxine | 1 | 2012 | 62 | 0.030 |
Why?
| | Microscopy, Electron | 1 | 2012 | 418 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2012 | 120 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2012 | 333 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2012 | 373 | 0.020 |
Why?
| | Subcellular Fractions | 1 | 2011 | 80 | 0.020 |
Why?
| | Antioxidants | 2 | 2008 | 557 | 0.020 |
Why?
| | Infant, Newborn | 2 | 2014 | 5752 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2012 | 539 | 0.020 |
Why?
| | Cholesterol | 1 | 2013 | 399 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2013 | 305 | 0.020 |
Why?
| | Species Specificity | 1 | 2012 | 567 | 0.020 |
Why?
| | RNA Interference | 1 | 2012 | 448 | 0.020 |
Why?
| | Mutation | 1 | 2021 | 3674 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2012 | 436 | 0.020 |
Why?
| | Models, Chemical | 1 | 2012 | 263 | 0.020 |
Why?
| | Superoxide Dismutase | 2 | 2003 | 329 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2012 | 640 | 0.020 |
Why?
| | Thromboxane B2 | 1 | 2009 | 26 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2012 | 833 | 0.020 |
Why?
| | Constriction | 1 | 2009 | 44 | 0.020 |
Why?
| | Aorta, Abdominal | 1 | 2009 | 45 | 0.020 |
Why?
| | Adolescent | 2 | 2021 | 20355 | 0.020 |
Why?
| | Arachidonic Acid | 1 | 2009 | 114 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 962 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 3893 | 0.020 |
Why?
| | Thromboxanes | 1 | 2008 | 15 | 0.020 |
Why?
| | Rats, Mutant Strains | 1 | 2008 | 23 | 0.020 |
Why?
| | Cytochromes c | 1 | 2008 | 61 | 0.020 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2011 | 431 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2012 | 2051 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2018 | 1632 | 0.020 |
Why?
| | Hemodynamics | 1 | 2013 | 1097 | 0.020 |
Why?
| | Phosphorylation | 1 | 2013 | 1687 | 0.020 |
Why?
| | Diet, Fat-Restricted | 1 | 2008 | 79 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2012 | 2848 | 0.020 |
Why?
| | Heart Transplantation | 1 | 2014 | 713 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5050 | 0.020 |
Why?
| | Dietary Carbohydrates | 1 | 2008 | 154 | 0.020 |
Why?
| | Cell Death | 1 | 2008 | 342 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 7074 | 0.020 |
Why?
| | Isomerism | 1 | 2005 | 48 | 0.020 |
Why?
| | Cytokines | 1 | 2013 | 2008 | 0.020 |
Why?
| | Cell Size | 1 | 2005 | 87 | 0.020 |
Why?
| | Pulmonary Artery | 1 | 2011 | 1093 | 0.020 |
Why?
| | Proteinuria | 1 | 2005 | 89 | 0.020 |
Why?
| | RNA | 1 | 2011 | 877 | 0.010 |
Why?
| | Cell Separation | 1 | 2005 | 313 | 0.010 |
Why?
| | Leptin | 1 | 2005 | 218 | 0.010 |
Why?
| | Exercise Test | 1 | 2007 | 620 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2012 | 2522 | 0.010 |
Why?
| | Blood Glucose | 1 | 2013 | 2090 | 0.010 |
Why?
| | Ditiocarb | 1 | 2002 | 3 | 0.010 |
Why?
| | Fluoresceins | 1 | 2002 | 47 | 0.010 |
Why?
| | Survival Analysis | 1 | 2005 | 1297 | 0.010 |
Why?
| | Tibia | 1 | 2003 | 183 | 0.010 |
Why?
| | Chelating Agents | 1 | 2002 | 68 | 0.010 |
Why?
| | Calcium Radioisotopes | 1 | 2001 | 3 | 0.010 |
Why?
| | Adenylate Kinase | 1 | 2001 | 26 | 0.010 |
Why?
| | Adenosine Diphosphate | 1 | 2001 | 78 | 0.010 |
Why?
| | Adenosine Monophosphate | 1 | 2001 | 62 | 0.010 |
Why?
| | Chickens | 1 | 2001 | 187 | 0.010 |
Why?
| | Sodium | 1 | 2000 | 204 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2003 | 739 | 0.010 |
Why?
| | Electric Conductivity | 1 | 1998 | 94 | 0.010 |
Why?
| | NF-kappa B | 1 | 2002 | 687 | 0.010 |
Why?
| | Nitric Oxide | 1 | 2002 | 894 | 0.010 |
Why?
| | Proteins | 1 | 2002 | 948 | 0.010 |
Why?
| | Brain | 1 | 1998 | 2596 | 0.000 |
Why?
|
|
Sparagna's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|